AzTrials
AzTrials

Physical Therapy PatientNCT07277634

Cultural Adaptation of Attitude Scales Towards Artificial Intelligence Into Turkish

An observational study of Physical Therapy Patient, run by Barış SEVEN.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The rapid proliferation of artificial intelligence (AI) applications in healthcare has led to significant transformations, particularly in applications such as patient management, treatment planning, clinical decision support systems, and remote rehabilitation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Physical Therapy Patient
How many people
200 participants
Where
No sites listed yet
Study dates
1 Jan 2026to 1 Jan 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients undergoing active treatment in the Physical Therapy and rehabilitation unit

Who may be able to join

  • Patients undergoing active treatment in the Physical Therapy and rehabilitation unit.
  • Being cognitively able to answer the questionnaire.

Who cannot join

  • Severe communication or cognitive impairments.

About this study

Official title: Cultural Adaptation and Validity-Reliability of Attitude Scales Toward Artificial Intelligence in Turkish: A Psychometric Study on Physical Therapy Patients

The rapid proliferation of artificial intelligence (AI) applications in healthcare has led to significant transformations, particularly in applications such as patient management, treatment planning, clinical decision support systems, and remote rehabilitation. Ensuring that this transformation is effective and safe requires the reliable measurement of patients' perceptions and attitudes toward AI-based health technologies. However, the existing literature does not include any scales developed to measure patients' attitudes toward AI that have been adapted to Turkish society. This situation complicates both the assessment of acceptance of AI in clinical applications and the sound execution of scientific research in this field.

This research aims to culturally adapt the internationally developed ATTARI-12 (Attitudes Toward Artificial Intelligence-12) and ATTARI-WHE (Artificial Intelligence in Work, Health and Everyday Life) scales into Turkish and to evaluate their construct validity and reliability. The study is methodological in design and will be conducted at the Faculty of Health Sciences, Izmir Katip Celebi University, between January 2026 and January 2027, following approval by the ethics committee. The cultural adaptation method proposed by Beaton and colleagues, which includes forward translation, back translation, expert panel, and content validity stages, will be applied during the scale adaptation process; then, the understandability of the items will be tested with a pilot application. The sample will consist of at least 200 physical therapy patients, and convergent validity, construct validity using confirmatory factor analysis, and reliability using Cronbach's alpha and test-retest methods will be evaluated.

Read more

The project will be carried out according to a structured schedule consisting of project management, translation process, pilot application, data collection, and analysis stages. All measurements will be performed after obtaining ethical committee approval.

The results of this study will contribute to the literature by providing patient-specific, valid, and reliable measurement tools that can be used to scientifically evaluate patients' attitudes toward AI in Turkey. These scales are expected to have a widespread impact in national research, in the evaluation of clinical decision support systems, and in strategies aimed at increasing the acceptance of AI-based health technologies.

Read the detailed description

This is a Cultural Adaptation and Validity-Reliability study

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07277634
Study groupRoleWhat they receive
physical therapy patientsNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ATTARI-12 (Attitudes Toward Artificial Intelligence-12) and ATTARI-WHE (Artificial Intelligence in Work, Health and Everyday Life) Scales

    Measured: From January 2026 to January 2027

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Dec 2025
  2. Study start1 Jan 2026 (estimated)
  3. Primary completion1 Jun 2026 (estimated)
  4. Study completion1 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07277634
Sponsor's protocol ID
10
Status last verified
Nov 2025
First submitted
29 Nov 2025
Last updated
11 Dec 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Physical Therapy Patient, run by Barış SEVEN.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ATTARI-12 (Attitudes Toward Artificial Intelligence-12) and ATTARI-WHE (Artificial Intelligence in Work, Health and Everyday Life) Scales (time frame: From January 2026 to January 2027). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in